Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 May 28;8(4):458-472.
doi: 10.7150/ntno.95251. eCollection 2024.

Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor Targeting

Vaskuri G S Sainaga Jyothi  1 , Nagavendra Kommineni  2
Affiliations
Review

Peptide Conjugated Boron Neutron Capture Therapy for Enhanced Tumor Targeting

Vaskuri G S Sainaga Jyothi et al. Nanotheranostics. .

Abstract

A cutting-edge non-invasive cancer treatment method called boron neutron capture therapy (BNCT) allows for the removal of cancerous tumor cells with the least possible damage to healthy tissue. It involves the exposure of cancer cells with low-energy thermal neutrons, boron-10 (10B) cellular uptake causes cancer cell death by producing alpha particles and recoiling lithium-7 (7 Li) nuclei. Despite positive outcomes from clinical trials conducted all around the world, these substances have relatively limited tumor selectivity or low boron content per molecule. The development of new boron delivery agents with more selectivity and enhanced boron loading would advance this technique and promote its use in clinics as a primary cancer treatment. As peptide-binding cell surface receptors are typically overexpressed on cancer cells, they can be seen as interesting targets for targeted tumor therapy. The attachment of meta-carboranes to peptide conjugates that target tumor cells specifically by their overexpressed receptors may be a method to get around these problems. A state-of-the-art overview of current developments in the application of BNCT for cancer targeted therapy via peptide conjugation is the goal of this review.

Keywords: BNCT; Peptide conjugation; Tumor targeting; targeting peptides and BNCT designing.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: The authors have declared that no competing interest exists.

Figures

Figure 1
Figure 1
Neutron irradiated cancer cells containing boron compounds leads to cell death.
Figure 2
Figure 2
Chemical structures of (A) boronophenylalanine (BPA) and (B) sodium borocaptate (BSH)
Figure 3
Figure 3
Fluorescence imaging of U87MG human glioblastoma xenograft tumors in female mice was conducted using Cy5-conjugated cRGD-MID-BSA and MID-BSA. (a) Live images were taken 24 hours post-injection, and (b) ex vivo images of various organs were captured 24 hours after injection. Reprinted (adapted) with permission from . Copyright {2024} American Chemical Society.
Figure 4
Figure 4
(A) Treatment of mice with SZGO: Cr-10B-NF; (B) photographic images of the tumor, after irradiation with neutron; (C) plot of size of tumor versus number of days; (D) histopathological studies of treated and control tumor. Reprinted (adapted) with permission from . Copyright {2024} American Chemical Society.
See this image and copyright information in PMC

References

    1. Hu K, Yang Z, Zhang L. et al. Boron agents for neutron capture therapy. Coord Chem Rev. 2020;405:213139.
    1. Purohit M, Kumar M. Boron neutron capture therapy: History and recent advances. Mater Today Proc. 2022.
    1. Mitusova K, Peltek OO, Karpov TE, Muslimov AR, Zyuzin M V, Timin AS. Overcoming the blood-brain barrier for the therapy of malignant brain tumor: current status and prospects of drug delivery approaches. J Nanobiotechnology 2022 201 [Internet] 2022. [cited 6 April 2023]; 20: 1-40. Available at: https://link.springer.com/articles/10.1186/s12951-022-01610-7. - PMC - PubMed
    1. Seneviratne D, Advani P, Trifiletti DM, Exploring the Biological and Physical Basis of Boron Neutron Capture Therapy (BNCT) as a Promising Treatment Frontier in Breast Cancer. Vol. 14, Cancers. MDPI. 2022. - PMC - PubMed
    1. He H, Li J, Jiang P, The basis and advances in clinical application of boron neutron capture therapy. Radiat Oncol [Internet] 2021. [cited 6 April 2023]; 16: 1-8. Available at: https://link.springer.com/articles/10.1186/s13014-021-01939-7. - PMC - PubMed